pyridoxal phosphate has been researched along with Angioma in 7 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lesions in hepatocellular carcinomas patients showed a non-homogeneous enhancement pattern." | 1.33 | Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. ( Adigüzel, Y; Haykir, R; Karabacakoğlu, A; Karaköse, S; Kayaçetin, E, 2006) |
| "Hepatocyte-containing liver neoplasms such as hepatomas or focal nodular hyperplasia (FNH), take up MnDPDP and demonstrate varying degrees of enhancement." | 1.31 | MnDPDP enhanced magnetic resonance imaging of focal liver lesions. ( Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| King, LJ | 1 |
| Burkill, GJ | 1 |
| Scurr, ED | 1 |
| Vlavianos, P | 1 |
| Murray-Lyons, I | 1 |
| Healy, JC | 1 |
| Chung, JJ | 2 |
| Kim, MJ | 1 |
| Kim, KW | 1 |
| Karabacakoğlu, A | 1 |
| Adigüzel, Y | 1 |
| Karaköse, S | 1 |
| Kayaçetin, E | 1 |
| Haykir, R | 1 |
| Kettritz, U | 1 |
| Schlund, JF | 1 |
| Wilbur, K | 1 |
| Eisenberg, LB | 1 |
| Semelka, RC | 2 |
| Martin, DR | 1 |
| Balci, NC | 1 |
| Wilber, K | 1 |
| Helmberger, TK | 1 |
| Laubenberger, J | 1 |
| Rummeny, E | 1 |
| Jung, G | 1 |
| Sievers, K | 1 |
| Döhring, W | 1 |
| Meurer, K | 1 |
| Reiser, MF | 1 |
| Bernardino, ME | 1 |
2 trials available for pyridoxal phosphate and Angioma
| Article | Year |
|---|---|
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc | 2006 |
MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast | 2002 |
5 other studies available for pyridoxal phosphate and Angioma
| Article | Year |
|---|---|
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nod | 2002 |
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc | 2006 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gado | 1996 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia | 2000 |
Clinical hepatic imaging with paramagnetic positive enhancers.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms | 1991 |